HMEJ-mediated Site-specific Integration of a Myostatin Inhibitor Increases Skeletal Muscle Mass in Porcine
Overview
Authors
Affiliations
As a robust antagonist of myostatin (), follistatin () is an important regulator of skeletal muscle development, and the delivery of to muscle tissue represents a potential therapeutic strategy for muscular dystrophies. The N terminus and FSI domain of are the functional domains for binding. Here, we aimed to achieve site-specific integration of FSI-I-I, including the signal peptide, N terminus, and three FSI domains, into the last codon of the porcine gene using a homology-mediated end joining (HMEJ)-based strategy mediated by CRISPR-Cas9. Based on somatic cell nuclear transfer (SCNT) technology, we successfully obtained FSI-I-I knockin pigs. H&E staining of longissimus dorsi and gastrocnemius cross-sections showed larger myofiber sizes in FSI-I-I knockin pigs than in controls. Moreover, the Smad and Erk pathways were inhibited, whereas the PI3k/Akt pathway was activated in FSI-I-I knockin pigs. In addition, the levels of , , and transcription were upregulated while that of was downregulated in FSI-I-I knockin pigs. These results indicate that the FSI-I-I gene mediates skeletal muscle hypertrophy through an -related signaling pathway and the expression of myogenic regulatory factors. Overall, FSI-I-I knockin pigs with hypertrophic muscle tissue hold great promise as a therapeutic model for human muscular dystrophies.
Fu B, Ma H, Huo X, Zhu Y, Liu D Biomolecules. 2024; 14(11).
PMID: 39595585 PMC: 11591810. DOI: 10.3390/biom14111409.
Loss of MuRF1 in Duroc pigs promotes skeletal muscle hypertrophy.
Li J, Hu Y, Li J, Wang H, Wu H, Zhao C Transgenic Res. 2023; 32(3):153-167.
PMID: 37071377 DOI: 10.1007/s11248-023-00342-0.
Hu Z, Wu Y, Xiao R, Zhao J, Chen Y, Wu L Front Genet. 2023; 14:1115831.
PMID: 36968612 PMC: 10033665. DOI: 10.3389/fgene.2023.1115831.
Liu Z, Wu T, Xiang G, Wang H, Wang B, Feng Z Int J Mol Sci. 2022; 23(13).
PMID: 35806334 PMC: 9266401. DOI: 10.3390/ijms23137331.
TERT Promoter Revertant Mutation Inhibits Melanoma Growth through Intrinsic Apoptosis.
Wang Y, Chen Y, Li C, Xiao Z, Yuan H, Zhang Y Biology (Basel). 2022; 11(1).
PMID: 35053139 PMC: 8773187. DOI: 10.3390/biology11010141.